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Abstract
TAL (transcription activator-like) effectors are translocated by Xanthomonas bacteria into plant cells where they activate
transcription of target genes. DNA target sequence recognition occurs in a unique mode involving a central domain of
tandem repeats. Each repeat recognizes a single base pair in a contiguous DNA sequence and a pair of adjacent
hypervariable amino acid residues per repeat specifies which base is bound. Rearranging the repeats allows the design of
novel TAL proteins with predictable DNA-recognition specificities. TAL protein-based transcriptional activation in plant cells
is mediated by a C-terminal activation domain (AD). Here, we created synthetic TAL proteins with designed repeat
compositions using a novel modular cloning strategy termed ‘‘Golden TAL Technology’’. Newly programmed TAL proteins
were not only functional in plant cells, but also in human cells and activated targeted expression of exogenous as well as
endogenous genes. Transcriptional activation in different human cell lines was markedly improved by replacing the TAL-AD
with the VP16-AD of herpes simplex virus. The creation of TAL proteins with potentially any desired DNA-recognition
specificity allows their versatile use in biotechnology.
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Introduction
Transcription activator-like (TAL) effectors include key viru-
lence factors of Xanthomonas that bind to promoter regions of plant
genes and act as DNA sequence-specific transcriptional activators
[1,2,3,4]. As a typical feature, TAL effectors contain a central
domain of tandem repeats (1 to 33.5 repeats of typically 34 amino
acids) [1]. First shown for the archetype TAL effector AvrBs3, this
repeat domain is essential for DNA-binding [5,6] and represents a
novel, modular type of DNA-binding domain [5]. One repeat
corresponds to one DNA base pair, and the specificity of each
repeat is encoded by two hypervariable amino acids (position 12
and 13) per repeat, also termed repeat-variable diresidue (RVD)
[7,8]. The last repeat contains only the first 20 conserved residues
including the RVDs and is referred to as a half repeat. Each repeat
functions neighbor-independently, and the linear order of repeats
defines the matching DNA-sequence. In addition, the target box is
extended by a 59 T [1,2,7,8]. Based on the repeat-specificity code,
the target DNA specificities of several TAL effectors were correctly
predicted [7,9,10]. While the number of repeats greatly varies in
TAL effector family members, at least 10.5 repeats are required
for maximal activity [7]. Accordingly, TAL effectors with different
numbers of repeats (e.g. Hax2, 21.5 repeats and Hax3, 11.5
repeats) [11] show comparable transcriptional activation in
reporter assays [7]. The modular architecture, a hallmark of the
TAL protein repeat domain, enables simple rearrangements of
desired repeat orders. Thus, TAL proteins with novel and clearly
predictable DNA-recognition specificities can be constructed
[7,12,13,14,15,16,17].
The possibility of generating proteins with programmed DNA-
binding specificity is an exciting avenue to targeted genome editing
and gene regulation. For these purposes, zinc finger (ZF) proteins
that contain an array of ZFs targeting a given DNA sequence are
already in use [18,19]. Specifically, ZF-nucleases representing
fusions between ZF proteins and the nuclease domain of the
restriction enzyme FokI were applied to induce insertions and
deletions at specific sites in complex genomes [19,20]. Compared
to ZF proteins, the DNA-binding specificities of TAL proteins are
considerably easier to predict [1,19]. Thus, TAL-nucleases were
recently generated that cut specific DNA sites [12,13,14,21,22].
During preparation of this manuscript, initial studies showed that
TAL protein derivatives can induce the expression of human genes
[14,17].
TAL effector-mediated transcriptional activation requires the
C-terminal region of the protein. This region was suggested to take
on the role of transcription activation as it shows similarities to
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19509acidic transcriptional activation domains (ADs) [23,24,25]. So far,
this notion was supported by infection experiments with
Xanthomonas strains delivering TAL effectors where the C-terminus
was deleted or substituted by the AD of the herpes simplex virus
(HSV) transcription activator VP16. Monitored via elicited plant
responses and in yeast reporter assays, TAL effector activity was
inhibited without AD, while it was partly restored by the
heterologous VP16-AD [23,24,25,26].
Construction of TAL proteins with ordered repeats is challenging
due to the highly repetitive nature of the repeats. We developed a
modular cloning strategy to easily assemble TAL proteins and tested
the TAL-dependent modulation of gene expression in human cells.
We show that native TAL proteins function as transcriptional
activators in different human cell lines and that this activity can be
significantly enhanced by substituting the endogenous AD by the
VP16 AD. Importantly, specifically designed TAL effector deriva-
tives were shown to induce the expression of an exogenous reporter
gene as well as of target endogenous genes.
Results
The TAL protein-AD can be functionally replaced by ADs
from other organisms
To generate TAL proteins with a potential transcription factor
activity in non-plant organisms, we deleted the ADs from the TAL
effectors AvrBs3 and Hax3 and replaced them with the ADs of the
HSV VP16 and the yeast GAL4 transcription activators, respec-
tively (Figure S1A). All TAL proteins were designed such that they
contained an N-terminal tag of green fluorescent protein (GFP).
Following heterologous expression, all TAL proteins were con-
firmed to localize to plant nuclei indicating functionality of their
nuclear localization signals (NLSs) and thus protein integrity (Figure
S2). To determine the transcription factor activity of the TAL
effector-derivatives in plant cells, a reporter assay was set up. Target
DNA sequences specifically recognized by AvrBs3 and Hax3
(termed AvrBs3- and Hax3-box, respectively) were inserted
upstream of a minimal promoter which has low background activity
[27] into a reporter vector containing a promoterless uidA (b-
glucuronidase, GUS) reporter gene [7] (Figures 1A and S1B). The
reporter constructs wereco-transfected into Nicotiana benthamiana leaf
cells together with constructs that mediated the expression of the
avrBs3- and hax3-derivatives, respectively (Figure 1A).
Quantification of GUS activity revealed that AvrBs3 and Hax3
only induced promoters that contained the AvrBs3- and Hax3-
box, respectively. As expected, deletion of the ADs strongly
reduced the transcription factor activity of both effectors
(Figure 1B,C). Addition of the VP16-AD and GAL4-AD led to a
slight increase of the AvrBs3- and Hax3-activities in planta;
however, activity was still substantially lower than that of the
original TAL proteins (Figure 1B,C). These data show that AvrBs3
and Hax3 still contain approx. 15% of their activity after deletion
of the AD, and that the VP16-AD only partially complements the
natural TAL protein-AD in planta.
TAL protein-directed transcriptional activation in human
cells
Plant-infecting xanthomonads are not pathogenic to humans
and there is no indication that the bacteria can translocate TAL
effectors into cells of non-plant organisms. TAL proteins were
nevertheless expected to specifically interact and to even function
with matching DNA-sequences in non-plant organisms. This
notion was fuelled by the observation that in planta as well as in
vitro, the specificity of TAL protein-DNA interactions is solely
dependent on the TAL protein repeat composition [5,6,10,28].
Moreover, there are no indications for the existence of kingdom
specific eukaryotic host factors contributing to TAL protein
functions.
To test if TAL proteins were able to direct gene expression in
human cells, we established reporter constructs that contained the
AvrBs3- or Hax3-box upstream of a minimal human cytomega-
lovirus (CMV) promoter and a luciferase (luc) reporter gene
(Figures 2A and S1B). When either reporter plasmid was co-
transfected into human Hek293T-Rex cells together with a
plasmid that expressed GFP via a fully active CMV promoter,
only weak luciferase activity was detectable. This confirmed that
the minimal CMV promoter only has a low basal activity
(Figure 2B,C). In contrast, co-expression of native AvrBs3 or
Hax3 resulted in a specific activation of promoters with matching
target DNA boxes, respectively (Figure 2B,C). Interestingly, the
Figure 1. The VP16 or GAL4 activation domains (ADs) can
partially complement the endogenous ADs of AvrBs3 and
Hax3 in planta. (A) Schematic drawing of reporter construct and co-
transfection experiment. Target AvrBs3 and Hax3 boxes were inserted
upstream of the minimal Bs4 promoter into a GUS reporter vector [7].
GUS reporter and constructs driving expression of TAL genes were co-
delivered via Agrobacterium into N. benthamiana leaf cells. (B) Specific
induction of the AvrBs3 box by AvrBs3, an AD deletion mutant (DAD),
the DAD mutant complemented with the VP16-AD (VP16), and the DAD
mutant complemented with the GAL4-AD (GAL4). (C) Specific induction
of the Hax3 box by Hax3 and AD-derivatives. (B, C) GFP and
constitutively expressed GUS served as negative and positive controls,
respectively. Samples were taken 2 dpi (error bars indicate SD; n=3).
GUS activity was measured with MUG (4-methylumbelliferyl-b-D-
glucuronide) as substrate. 4-MU, 4-methylumbelliferone.
doi:10.1371/journal.pone.0019509.g001
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Hax3-derivatives with deleted ADs. Conversely, AvrBs3 and Hax3
that contained a VP16-AD caused a strong transcriptional
activation of the luciferase reporter gene, i.e., transcription
activation was 2–3 times higher than that induced by the original
(in planta active) AvrBs3 and Hax3 and 50–80 times higher than
transcription in the negative control (Figure 2B,C). In comparison,
the GAL4-AD did not increase the activity of the DAD-TAL
proteins significantly. Importantly, all expressed TAL proteins
were found to localize to the nucleus of the human cells indicating
correct nuclear import in the heterologous host (Figure S3A).
Protein levels of TAL effector-derivatives expressed in human cells
were comparable (Figure S3B,C). Our data show that TAL
proteins are capable to specifically induce gene expression in
human cells and that substitution of the endogenous AD by a
VP16-AD strongly increases transcriptional activity.
Next, we analyzed whether the TAL protein-directed transcrip-
tional activation was functional in different human cell lines. As
also shown in Figure 2D, analogous experiments that were
performed with TAL-VP16 derivatives and reporter constructs in
Hek293T-Rex (human embryonic kidney) cells, Huh7 (hepato-
carcinoma) cells, and HeLa (cervical cancer) cells led in each case
to an evident and specific induction of reporter gene activity in
matching TAL protein-target box combinations (Figure 2D). In
sum, these results demonstrate that TAL effector-derivatives are
functional as transcriptional activators in different human cells.
A modular cloning strategy to assemble TAL proteins
with designed repeat architecture
To target defined DNA sequences and individual promoters
with TAL proteins it is required to control their order of repeats.
Unfortunately, the repetitive nature of TAL effector repeats makes
it inherently complicated to use classical or PCR-based cloning
techniques to generate TAL proteins with a given order of repeats.
For that reason, we established a rapid and flexible cloning
technique (Figure 3 and S4, see Text S1 for details).
Single TAL protein repeats were cloned as individual modules
with flanking BpiI restriction sites. The type IIs sites were designed
to generate specific overhangs that determine the position of the
repeat in a repeat array (Figure 3A) while preserving the amino
acid sequence. For each repeat position, four key repeats (NI, HD,
NN, NG) were cloned that specify the four DNA base pairs. Using
a BpiI cut-ligation reaction, one to six repeats can be combined
into an assembly vector that contained additional flanking BsaI
sites which specify the position of the repeat assembly in the final
repeat domain (Figure 3B). In addition, BsaI-flanked modules of
the TAL protein N-terminal region and C-terminal region fused to
VP16, and an N-terminal GFP-module were designed. In a BsaI
cut-ligation reaction, these modules can be specifically aligned into
a vector backbone (Figure 3C). With a plasmid library of only 29
repeat modules and seven different assembly vectors, synthetic
TAL proteins with 1 to 24 specific repeats can be generated in a
matter of days. The modular technology also allows a simple
integration of an expanded module toolbox with different TAL
protein termini, tags, and vectors. Since this toolbox is essentially
based on golden gate cloning [29,30], we termed this cloning
strategy ‘‘Golden TAL Technology’’.
Designed TAL proteins direct the expression of
endogenous human genes
Next, we considered it important to evaluate whether synthetic
TAL proteins were also applicable to activate the transcription
and thus the expression of different endogenous human genes.
Figure 2. AvrBs3 and Hax3 activate transcription in human
cells. (A) Schematic drawing of reporter construct and co-transfection
experiment. TAL boxes were cloned upstream of a minimal cytomeg-
alovirus (CMV) promoter into a luciferase (luc) reporter vector. The l
operators are bound by a chimeric transactivator used as control. The
Luc reporter plasmids were co-transfected into human Hek293T-Rex
cells together with expression plasmids where transcription of the TAL
or GFP genes was driven by a fully active CMV promoter. (B) Specific
induction of the AvrBs3 box by AvrBs3, an AD deletion mutant (DAD),
the DAD mutant complemented with the VP16-AD (VP16), and the DAD
mutant complemented with the GAL4-AD (GAL4). (C) Specific induction
of the Hax3 box by Hax3 and AD-derivatives. (D) Comparison of
induction levels of the Luc reporter plasmids using Hax3 with VP16-AD
or via co-transfection of a plasmid expressing a chimeric transactivator
for the l operator and addition of the inducer coumermycin (light grey
bars), respectively, in Hek293T-Rex cells. (E) Specific activity of AvrBs3
and Hax3 containing the VP16-AD, respectively, in human Huh7, and
HeLa cells. (B-E) Measurements were done 1 dpi. Luc activity was
plotted in arbitrary light units per mg protein. Dark grey bars: AvrBs3,
white bars: Hax3. The activation is statistically significant (relative to
GFP) with P#0.005 for all values except AvrBs3-DAD, P#0.01.
doi:10.1371/journal.pone.0019509.g002
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artificial TAL proteins with repeats that matched DNA sequences
in promoter regions of the human PUMA (p53 upregulated
modulator of apoptosis), an interferon alpha (IFNa1), and an
interferon beta (IFNb1) gene, respectively (Figure S5A). PUMA is
a pro-apoptotic member of the Bcl-2 protein family [31,32],
whereas IFNa1 and IFNb1belong to type I interferons that are
involved in the innate immune response in humans against viral
infections [33,34]. To efficiently direct human gene expression, the
designed ‘‘human TAL proteins’’ (HuTALs) contained a C-
terminal VP16 activation domain. Protein levels of HuTALs
expressed in human cells were comparable and the proteins
localized to the nucleus of human cells (Figure S5B,C).
As an important pilot experiment, we first inserted the predicted
target DNA boxes of the HuTALs into the reporter vector
described above, i.e., upstream of the minimal CMV promoter
and the promoterless luc gene (Figure 2A). Co-transfection
of human Hek293T-Rex cells with the reporter constructs and
HuTAL expression plasmids resulted in a strong (22- to 34-fold)
and specific induction of reporter activity only in matching TAL
protein-target DNA box combinations (Figure 4A). Thus, we
confirmed the specificity and functionality of the HuTALs.
Next, we transfected Hek293T-Rex cells with the CMV
promoter-driven HuTAL genes to address if we could also affect
the expression of endogenous human genes by the HuTALs.
These experiments revealed that expression of the respective
HuTAL in each case caused moderately increased levels of target
endogenous human gene transcript levels (Figure 4B). While
PUMA transcript levels were only slightly induced (1.5 x), the
IFNa1 and IFNb1 levels were 3.1-fold and 3.5-fold up-regulated,
respectively (Figure 4B).
TAL protein-directed induction of endogenous gene expression
was considerably lower than with our reporter constructs. This
prompted us to determine if the promoter per se has an influence
on TAL protein functionality. Hence, we replaced the minimal
CMV promoter in the reporter plasmid by the native IFNb1
promoter sequence. Co-transfection of the IFNb1 reporter
construct with the HuTAL targeting this promoter led to a
moderate, 3.2-fold induction of reporter activity (Fig. 4C)
Figure 3. Golden TAL Technology for assembly of TAL proteins
with programmed repeat composition. (A) Single TAL repeats
were cloned with flanking BpiI sites that generate specific four base
pair-overhangs (a–g). Matching sites are indicated by identical letters. A
library was constructed with four different repeat types (RVD, repeat
variable di-residue: NI, HD, NN, NG) for each repeat position. The repeat
types have different DNA-specificities (Spec., only upper DNA-strand is
shown). (B) One to six repeats are assembled in specific order into an
assembly vector to generate a repeat assembly with flanking BsaI sites.
(C) TALs were directly assembled with N-terminal GFP-tag into an
expression vector using fragments with matching BsaI-generated
overhangs (capital letters). Insertion of one to four repeat assemblies
generated TALs with 1 to 24 repeats. The last repeat is only a half repeat
as typical for TAL proteins. Please see the Text S1 and Figure S4 for
details.
doi:10.1371/journal.pone.0019509.g003
Figure 4. Designed TAL proteins induce expression of human
genes. Artificial TAL proteins (HuTALs) containing a VP16-AD were
constructed that target promoter regions of human PUMA, IFNa1,o r
IFNb1 genes. (A) Target DNA boxes were cloned upstream of the
minimal CMV promoter into the luc reporter vector. Luc reporter
constructs were co-transfected with constructs driving TAL gene
expression into human Hek293T-Rex cells. Measurements were done
1 dpi (error bars indicate SD). Luc activity was plotted in arbitrary light
units per mg protein. (B) TAL protein-directed expression of endogenous
human genes. Plasmids expressing HuTALs or Hax3 were transfected
into human Hek293T-Rex cells. mRNAs levels of target genes were
determined by quantitative real-time PCR. mRNA levels in presence of
Hax3 (negative control, white bars) were set to 1. (C) The natural IFNb1
promoter was cloned into the luc reporter vector. The IFNb1 reporter
was co-transfected with constructs directing expression of HuTALIFNb1
or hax3, respectively. Dark grey bars: HuTAL, white bars: Hax3. (A,C)
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suggests that the efficiency of TAL proteins also depends on the
individual target promoter. Taken together, our experiments show
that TAL protein-derivatives can be used to specifically induce
expression of human endogenous genes and demonstrate the
functionality of the TAL protein technology in other organisms
besides plants.
Discussion
In this report we demonstrate that TAL protein derivatives can
be used to specifically modulate the transcription of genes in
human cells. Our findings confirm and extend the recent work of
Miller et al. [14] and Zhang et al. [17]. In addition to those studies,
we report here that native Xanthomonas TAL effectors (AvrBs3 and
Hax3) exhibited considerable activity in the heterologous host
cells. This is surprising considering that these are proteins from
bacterial origin that were evolutionary shaped to function in plant
cells. Two scenarios are conceivable to interpret this finding. On
one hand, the mechanism that is applied by TAL proteins to
activate the host’s transcription machinery may be based on the
protein structure itself. Alternatively, TAL proteins may rely on
elements that are conserved in the different hosts. Hence, it will be
interesting to see if TAL proteins function ubiquitously in all
eukaryotes or if there is a specific host determinant required for
activity.
Deletion of the endogenous TAL protein activation domain
(AD) strongly compromized transcriptional activation, but a
measurable residual activity remained (Figs. 1 and 2). This finding
supports two conclusions. First, the endogenous TAL-AD is clearly
a major determinant of TAL protein function also in heterologous
hosts, and, second, TAL proteins have a low but specific residual
transcriptional activation activity, irrespective of the presence of
the AD. This has not been demonstrated before, and suggests that
this low activity is based on TAL-DNA interactions, which are not
influenced by the AD [5], or possible AD-independent interactions
with components of the host transcription machinery.
The substitution of the endogenous AD by the heterologous
HSV VP16-AD strongly elevated the activity of AvrBs3 and Hax3
DAD derivatives in human cells but not in plant cells (Figs. 1, 2
and 4). The human virus AD is adapted to function in human
cells, and this function can be transferred to TAL proteins. Miller
et al. [14] and Zhang et al. [17] applied artificial TAL proteins,
where the VP16-AD was fused to full-length or C-terminally
truncated TAL proteins. The TAL proteins designed by Miller
et al. [14] and Zhang et al. [17] as well as our synthetic TAL
proteins each activated gene expression in human cells indicating
that the VP16-AD functions in two ways, as a substitute or as a
supplement of the endogenous TAL-AD. In addition, we showed
that TAL-VP16 fusions are active in different human cell lines
(Fig. 2D). The TAL protein activity strongly varied between HEK
cells showing highest and HeLa cells showing lowest transcrip-
tional activation, respectively. Likely, this is in part due to different
transfection efficiencies that were achieved with the different cell
lines. Further studies will clarify if tissue-specific requirements exist
or whether different TAL protein backbones (N- and C-termini)
function differently well in human cells.
We designed the Golden TAL Technology as a toolbox for a
flexible assembly of TAL proteins with designed repeats, different
N-, C-termini, and tags. While our method is somewhat similar to
the recently published method of Zhang et al. [17], it includes a
number of aspects that we consider advantegous for the
construction of designer TAL proteins. First, our procedure does
not rely on PCR but instead uses plasmid sub-clones of single
repeats which is user-friendly and prohibits PCR-based errors.
Furthermore, Zhang et al. [17] altered the codon usage between
TAL protein repeats to allow efficient PCR, while we preferred to
keep the codon usage near-identical between repeats to reduce
repeat-specific effects on translation. Second, our library consists of
only 24 single-repeat plasmids, instead of the 48 PCR-library of
Zhang et al. [17]. Third, our method allows construction of TAL
proteins with a flexible number of repeats. At present TAL
proteins with 1 to 24 repeats can be constructed based on assembly
modules containing six or less individual repeats. Fourth, we
designed the restriction overhangs such that they differ each at a
minimum of two positions. We found this to be essential for an
efficient error-free ligation. Finally, we employ the full power of
Golden Gate cloning which is a fast and versatile method to
assemble many fragments specifically in a one-step cut-ligation
reaction [29,30]. To acknowledge this, we termed our cloning
strategy Golden TAL Technology.
Taking advantage of the Golden TAL Technology we were able
to straightforwardly construct artificial TAL proteins with VP16-
AD and repeats that match to promoters of various human target
genes. These tailored TAL proteins (HuTALs) strongly induced
reporter gene activation more than 30-fold and also endogenous
human PUMA, IFNa1, and IFNb1 mRNA levels. Endogenous
gene induction was considerably weaker (1.5-fold to 3.5-fold), a
phenomenon which was also observed with artificial ZF
transcription factors [35,36]. The efficiency of TAL protein-
dependent endogenous human gene induction in the two recent
studies varied. While Miller et al. [14] activated endogenous NTF3
expression 20-fold, Zhang et al. [17] induced endogenous human
SOX2 and KLF4 genes only 2.2 and 5.5 fold, respectively, or were
not able to change expression levels of c-MYC and OCT4 at all.
This observation makes sense considering that in the transient
transfection experiments, multiple reporter gene copies are
applied, whereas the endogenous genes are present at much lower
copy-number. Moreover, the epigenetic environment of the
endogenous genes (nucleosome packaging, transcriptional inter-
ference with other regulatory factors, etc.) may significantly affect
the activity of HuTALs. This may also explain, why in the case of
the PUMA gene no phenotype (accelerated cell death) could be
observed. Hence, future optimization of the HuTAL system will be
necessary to allow efficient regulation of endogenous human gene
expression.
A growing collection of studies shows that the programmable
DNA-binding specificity of TAL proteins renders these proteins
similarly useful as the ZF technology [19] for different biotech-
nology applications. Our work and the recently published ones
[14,17] are first crucial kick-off steps to use TAL proteins as highly
potent and specific gene switches in human cells.
Materials and Methods
Plant growth and inoculations
Nicotiana benthamiana plants were cultivated in the greenhouse
with day and night temperatures of 23uC and 19uC, respectively,
16 h light, and 40 to 60% humidity. Leaves of five- to seven-week-
old plants were inoculated with an Agrobacterium suspension using a
needleless syringe [7]. Inoculated plants were transferred to a
Percival growth chamber (Percival Scientific) with day and night
temperatures of 22uC and 18uC, respectively, and 16 h light.
Cell culture and transfection
Hek293T-Rex, HeLa and Huh7 cells were grown under
standard conditions [37] in DMEM (Invitrogen) supplemented
with 10% FCS (Invitrogen), 1% non-essential amino acids and 1%
Programmable Transcriptional Activators
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with Turbofect in vitro Transfection Reagent (Fermentas).
Plasmids
For DAD constructs, the last 31 amino acids (aa) of AvrBs3 and
Hax3 were deleted, respectively. 68 aa of VP16, or 113 aa of
GAL4 were added as heterologous activation domains. Constructs
for TAL expression in planta and in human cells were based on
pVS300F [38] and pcDNA5 (Invitrogen), respectively. Reporter
plasmids for plant cells were constructed as described [7].
Reporter plasmids for human cells were based on pF12A RM
Flexi (Promega). The barnase gene of pF12A RM Flexi was
replaced by a luciferase gene. To generate plasmids containing the
recognition site of TALs, pF12A RM (Luc) was amplified with
primers containing target boxes. The promoter and 59 untrans-
lated region (675 bp) of the IFNb1 promoter were amplified by
PCR and inserted into the luciferase reporter plasmid. Further
details on constructs and methods are given in the supplementary
information and upon request.
GUS assays
GUS assays from plant samples were essentially done as
described [7]. Briefly, Agrobacterium strains delivering TAL effector
constructs and GUS reporter constructs were mixed in equal
amounts, and inoculated into Nicotiana benthamiana leaves with an
OD600 of 0.8. Two days post infiltration (dpi), two leaf discs
(0.9 cm diameter) were sampled and quantitative GUS activity
was determined using 4-methyl-umbelliferyl-b-D-glucuronide
(MUG). Proteins were quantified by Bradford assays (BioRad).
Data points correspond to triplicate samples from different plants.
qRT-PCR, western blotting and luciferase assay
Human cells were harvested 24 h after transfection with
plasmids. For RNA extraction, a standard protocol was used as
described [37]. RNA was heated for 5 min to 70uC and reverse
transcription of DNaseI (Roche), EcoRI, and BglII (Fermentas)
treated RNA (2 mg) was performed by RevertAid H Minus
Reverse Transcriptase (Fermentas) for 1 h at 42uC, followed by
heat inactivation for 10 min at 70uC as described in the
manufacturer’s manual. Quantitative PCRs (for primers see Table
S1) were performed with the QuantiTect SYBR Green PCR Kit
(Qiagen) according to the manufacturer’s manual using a Light-
Cycler 2.0 instrument (Roche). PCR conditions were: 95uC
15 min, (95uC, 10 sec; 60uC, 25 sec; 72uC 25 sec) x 45 cycles. The
qRT-PCR data were normalized to GAPDH as internal control
and analyzed by the ddCt method [39]. For western blotting total
protein extracts were prepared with Luciferase Cell Culture Lysis
Reagent (Promega) and analyzed by western blotting for GFP (a-
GFP, Invitrogen) and Vinculin (hVin-1, Sigma-Aldrich). Lucifer-
ase assays were prepared as described in the Luciferase Assay
System (Promega). The data points were generated from three
biological replicates (separate transfections).
Golden TAL Technology
For details on individual modules, vectors, and cloning strategy
see Text S1 and Figure S4. Briefly, single repeats were PCR-
amplified with flanking BpiI sites (for primers see Table S1) and
subcloned by cut-ligation using SmaI and T4-DNA ligase into a
pUC57-derivative (Amp) with mutated BsaI site. The assembly
vectors (Kan) contain a lacZ gene flanked by BpiI sites which is
replaced in cloning step 1 by the inserted repeats and used for
blue-white selection of correct assembly products. BsaI-flanked
modules are assembled in cloning step 2 into a target expression
vector. Assembly reactions were set up as cut-ligation with 50-
100 ng of each plasmid module, 1 ml BsaI (NEB), 2 ml ATP
(10 mM), 2 ml restriction buffer no. 4 (NEB), 1 ml T4-DNA ligase
(5 u/ml) in a 20 ml reaction for 1 h at 37uC followed by 20 min.
inactivation of enzymes at 70uC.
Supporting Information
Text S1 TAL gene expression constructs, reporter constructs,
the Golden TAL Technology toolbox, and promoter regions of
human genes chosen as targets for TAL protein-directed
expression.
(DOC)
Figure S1 TAL effector-derivatives and reporter constructs.
(A) Functional domains of TAL effector-derivatives used. The
endogenous C-terminal transcriptional activation domain (AD; C-
terminal 31 aa) was deleted or replaced by the ADs from herpes
simplex virus VP16 (C-terminal 68 aa) or yeast GAL4 (C-terminal
113 aa). NLS: nuclear localization signals; red: repeat domain of
AvrBs3 and derivatives; yellow: repeat domain of Hax3 and
derivatives. All constructs carried an N-terminal green fluorescent
protein (GFP) tag. (B) Reporter constructs used for transient
expression in plant and human cells, respectively. For experiments
in plants, TAL protein target DNA boxes were inserted in front of
a minimal Bs4 promoter which has low basal activity upstream of a
promoterless uidA (GUS) reporter gene as described [4]. For
studies with human cells, TAL protein target DNA boxes were
placed upstream of the minimal CMV promoter and a promoter-
less luciferase (luc) gene into a pF12A RM Flexi (Promega) reporter
vector. To study activity of the endogenous interferon b promoter,
the minimal CMV promoter was replaced by part of the INFb
promoter.
(TIF)
Figure S2 GFP-TAL protein fusions localized to the plant
nucleus. GFP-TAL protein fusions or GFP alone were expressed
transiently in leaf cells of Nicotiana benthamiana via Agrobacterium-
mediated delivery. Two days post infiltration, N. benthamiana leaf
epidermis cells were stained with DAPI (49,6-diamidino-2-
phenylindole) and analyzed by confocal laser scanning microsco-
py. Green: GFP fluorescence; blue: DAPI fluorescence; red:
chlorophyll autofluorescence. Scale bars indicate 50 mm.
(TIF)
Figure S3 GFP-TAL protein fusions are expressed and localize
to the nucleus in human cells. (A) GFP-TAL protein fusions or
GFP alone were expressed after transfection of human Hek293T-
Rex cells. One day post transfection, cells were stained with DAPI
(49,6-diamidino-2-phenylindole) and analyzed by fluorescence
microscopy. Green: GFP fluorescence; blue: DAPI fluorescence.
(B) Western-blot analysis of whole cell extracts of transfected
Hek293T-Rex cells. (C) TAL protein-derivatives expressed in
HeLa cells show degradation patterns. (B+C) GFP and GFP-TAL
protein fusions were detected using a-GFP antibody. An a-
Vinculin antibody was used as constitutive loading control.
(TIF)
Figure S4 Golden TAL Technology toolbox. Single repeat modules
were subcloned with flanking BpiI sites that specify their position in the
repeat array. A library of four repeat types (NI=A, HD=C, NN=G/
A, NG=T) was constructed for each of the six repeat positions. Stop
repeats (1s to 5s) can be used to terminate the repeat assembly. In
cloning step 1, up to six repeats are inserted into an assembly vector to
generate a repeat assembly. Different assembly vectors are used to
position the repeat assembly within the final TAL protein repeat
domain. In cloning step 2, individual repeat assemblies, Hax3 N- and
Programmable Transcriptional Activators
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19509C-termini, and an N-terminal GFP-tag are ligated into an expression
vector to generate the complete TAL gene.
(TIF)
Figure S5 HuTALs designed to target expression of human
genes. (A) HuTALs with 17.5 to 19.5 repeats matching a DNA
sequence (box) in the promoter region of target genes are
assembled as N-terminal GFP fusions using the ‘‘Golden TAL
technology’’. (B) GFP-TAL protein fusions were expressed after
transfection of human Hek293T-Rex cells. One day post
transfection, cells were stained with DAPI (49,6-diamidino-2-
phenylindole) and analyzed by fluorescence microscopy. Green:
GFP fluorescence; blue: DAPI fluorescence. (C) Western-blot
analysis of whole cell extracts of Hek293T-Rex cells transfected
with HuTAL expression constructs.
(TIF)
Table S1 Selected primers used in this study.
(DOC)
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